Literature DB >> 17667822

Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.

H Myron Kauffman1, Wida S Cherikh, Maureen A McBride, Yulin Cheng, Douglas W Hanto.   

Abstract

Approximately 2% of deceased donor organ transplants result from donors with a past history of cancer. An analysis of Organ Procurement and Transplantation Network/United Network for Organ Sharing data on 39,455 deceased donors from 2000 to 2005 showed 1069 donors had a PHC, resulting in 2508 transplants, including 1236 kidneys, 891 livers, 199 hearts, 100 lungs, and 82 miscellaneous organs. The most common type of previous cancer in the donor was nonmelanoma skin cancer (n=776) followed by central nervous system malignancies (n=642) and carcinoma of the uterine cervix (n=336). One donor with a glioblastoma multiforme transmitted fatal tumors to three recipients. One donor with a history of melanoma 32 years earlier transmitted a fatal melanoma to a single recipient and, therefore, donors with a history of melanoma should not be used. Donors with a past history of cancer who have a nontraumatic cerebral hemorrhage cause concern because this hemorrhage may be the result of an unrecognized metastatic tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17667822     DOI: 10.1097/01.tp.0000267919.93425.fb

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  22 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 2.  Surgical aspects of human islet isolation.

Authors:  Tatsuya Kin; A M James Shapiro
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

3.  Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

4.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

Review 5.  Post-transplantation malignancies: here today, gone tomorrow?

Authors:  Edward K Geissler
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

6.  Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.

Authors:  Krista L Lentine; Anitha Vijayan; Huiling Xiao; Mark A Schnitzler; Connie L Davis; Amit X Garg; David Axelrod; Kevin C Abbott; Daniel C Brennan
Journal:  Transplantation       Date:  2012-07-27       Impact factor: 4.939

7.  How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.

Authors:  Albino Eccher; Letizia Lombardini; Ilaria Girolami; Francesca Puoti; Gianluigi Zaza; Giovanni Gambaro; Amedeo Carraro; Giovanni Valotto; Luca Cima; Luca Novelli; Desley Neil; Umberto Montin; Aldo Scarpa; Matteo Brunelli; Alessandro Nanni Costa; Antonia D'Errico
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

Review 8.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Authors:  Laura M Shelton; Purna Mukherjee; Leanne C Huysentruyt; Ivan Urits; Joshua A Rosenberg; Thomas N Seyfried
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

Review 10.  Neoplastic disease after liver transplantation: Focus on de novo neoplasms.

Authors:  Patrizia Burra; Kryssia I Rodriguez-Castro
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.